Further Confirmation of Germline Glioma Risk Variant rs78378222 in TP53 and Its Implication in Tumor Tissues via Integrative Analysis of TCGA Data

Human Mutation

Volumn 36, Issue 7, 2015, Pages 684-688

  Wang, Zhaoming ^a,b   Rajaraman, Preetha ^a   Melin, Beatrice S ^c   Chung, Charles C ^a,b   Zhang, Weijia ^d   Mckean Cowdin, Roberta ^e   Michaud, Dominique ^f,g   Yeager, Meredith ^a,b   Ahlbom, Anders ^h   Albanes, Demetrius ^a   Andersson, Ulrika ^c   Freeman, Laura E Beane ^a   Buring, Julie E ⁱ   Butler, Mary Ann ^j   Carreón, Tania ^j   Feychting, Maria ^h   Gapstur, Susan M ^k   Gaziano, J Michael ^i,l   Giles, Graham G ^m,n   Hallmans, Goran ^c   Henriksson, Roger ^c   Hoffman Bolton, Judith ^o   Inskip, Peter D ^a   Kitahara, Cari M ^a   Marchand, Loic Le ^p   Linet, Martha S ^a   Li, Shengchao ^a,b   Peters, Ulrike ^q,r   Purdue, Mark P ^a   Rothman, Nathaniel ^a   Ruder, Avima M ^j   Sesso, Howard D ⁱ   Severi, Gianluca ^m,n   Stampfer, Meir ^s,t   Stevens, Victoria L ^k   Visvanathan, Kala ^o,u   Wang, Sophia S ^v   White, Emily ^q,r   Zeleniuch Jacquotte, Anne ^w   Hoover, Robert ^a   Fraumeni, Joseph F ^a   Chatterjee, Nilanjan ^a   Hartge, Patricia ^a   Chanock, Stephen J ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c UMEÅ UNIVERSITY   (Sweden)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f BROWN UNIVERSITY   (United States)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^k AMERICAN CANCER SOCIETY   (United States)

^l VA BOSTON HEALTHCARE SYSTEM   (United States)

^m CANCER EPIDEMIOLOGY CENTRE   (Australia)

ⁿ UNIVERSITY OF MELBOURNE   (Australia)

^o JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^p UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^q Fred Hutchinson Cancer Research Center   (United States)

^r UNIVERSITY OF WASHINGTON   (United States)

^s HARVARD MEDICAL SCHOOL   (United States)

^t HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^u JOHNS HOPKINS UNIVERSITY   (United States)

^v CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^w NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Glioma; Rare SNP; TCGA; TP53

Indexed keywords

PROTEIN P53;

ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; EXOME; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLIOMA; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; POLYADENYLATION; PRIORITY JOURNAL; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GROWTH; ADENOCARCINOMA; ADULT; BIOLOGY; CENTRAL NERVOUS SYSTEM TUMOR; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GLIOBLASTOMA; LUNG TUMOR; MIDDLE AGED; NUCLEIC ACID DATABASE; RISK; STATISTICS AND NUMERICAL DATA;

ADENOCARCINOMA; ADULT; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMPUTATIONAL BIOLOGY; DATABASES, NUCLEIC ACID; GENOME-WIDE ASSOCIATION STUDY; GLIOBLASTOMA; GLIOMA; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84931577278     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22799     Document Type: Article

References (18)

1. Bainbridge MN, Armstrong GN, Gramatges MM, Bertuch AA, Jhangiani SN, Doddapaneni H, Lewis L, Tombrello J, Tsavachidis S, Liu Y, Jalali A, Plon SE, et al. 2015. Germline mutations in shelterin complex genes are associated with familial glioma. J Natl Cancer Inst 107(1):dju384.
2. Diskin SJ, Capasso M, Diamond M, Oldridge DA, Conkrite K, Bosse KR, Russell MR, Iolascon A, Hakonarson H, Devoto M, Maris JM. 2014. Rare variants in TP53 and susceptibility to neuroblastoma. J Natl Cancer Inst 106(4):dju047.
3. Dolecek TA, Propp JM, Stroup NE, Kruchko C. 2012. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 14(Suppl 5):v1-v49.
4. Egan KM, Nabors LB, Olson JJ, Monteiro AN, Browning JE, Madden MH, Thompson RC. 2012. Rare TP53 genetic variant associated with glioma risk and outcome. J Med Genet 49:420-421.
5. Enciso-Mora V, Hosking FJ, Di Stefano AL, Zelenika D, Shete S, Broderick P, Idbaih A, Delattre JY, Hoang-Xuan K, Marie Y, Labussiere M, Alentorn A, et al. 2013. Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. Br J Cancer 108:2178-2185.
6. Guan X, Wang LE, Liu Z, Sturgis EM, Wei Q. 2013. Association between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites. J Cell Mol Med 17:873-878.
7. Hemminki K, Tretli S, Sundquist J, Johannesen TB, Granstrom C. 2009. Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol 10:481-488.
8. Knudson AG Jr. 1971. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823.
9. Li Y, Gordon MW, Xu-Monette ZY, Visco C, Tzankov A, Zou D, Qiu L, Montes-Moreno S, Dybkaer K, Orazi A, Zu Y, Bhagat G, et al. 2013. Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program. Blood 121:4529-4540.
10. Melean G, Sestini R, Ammannati F, Papi L. 2004. Genetic insights into familial tumors of the nervous system. Am J Med Genet C Semin Med Genet 129C:74-84.
11. Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, Bondy M, Houlston R, Jenkins RB, Wrensch M, Yeager M, Ahlbom A, et al. 2012. Genome-wide association study of glioma and meta-analysis. Hum Genet 131:1877-1888.
12. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, Hoang-Xuan K, El Hallani S, et al. 2009. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41:899-904.
13. Stacey SN, Sulem P, Jonasdottir A, Masson G, Gudmundsson J, Gudbjartsson DF, Magnusson OT, Gudjonsson SA, Sigurgeirsson B, Thorisdottir K, Ragnarsson R, Benediktsdottir KR, et al. 2011. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet 43:1098-1103.
14. Walsh KM, Anderson E, Hansen HM, Decker PA, Kosel ML, Kollmeyer T, Rice T, Zheng S, Xiao Y, Chang JS, McCoy LS, Bracci PM, et al. 2013. Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studies. Genet Epidemiol 37:222-228.
15. Walsh KM, Codd V, Smirnov IV, Rice T, Decker PA, Hansen HM, Kollmeyer T, Kosel ML, Molinaro AM, McCoy LS, Bracci PM, Cabriga BS, et al. 2014. Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. Nat Genet 46:731-735.
16. Wang Z, Jacobs KB, Yeager M, Hutchinson A, Sampson J, Chatterjee N, Albanes D, Berndt SI, Chung CC, Diver WR, Gapstur SM, Teras LR, et al. 2012. Improved imputation of common and uncommon SNPs with a new reference set. Nat Genet 44:6-7.
17. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, Ballman KV, Berger M, Buckner JC, Chang S, Giannini C, Halder C, et al. 2009. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41:905-908.
18. Zhou L, Yuan Q, Yang M. 2012. A functional germline variant in the P53 polyadenylation signal and risk of esophageal squamous cell carcinoma. Gene 506:295-297.